PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Guardant Health Inc. (GH) on Wednesday reported a loss of $92.7 million in its third quarter.
On a per-share basis, the Palo Alto, California-based company said it had a loss of 74 cents. Losses, adjusted for stock option expense and non-recurring costs, were 39 cents per share.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 48 cents per share.
The provider of oncology testing services posted revenue of $265.2 million in the period, also surpassing Street forecasts. Eight analysts surveyed by Zacks expected $234.6 million.
Guardant Health expects full-year revenue in the range of $965 million to $970 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
